Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

June 2010 - FRMC

Department

News Connection
Product Updates
06/28/2010
The FDA approved alglucosidase alfa (Lumizyme) for patients ≥8 years of age with late-onset, noninfantile Pompe disease, a rare genetic disorder. Alglucosidase alfa, marketed by Genzyme Corporation, is believed to work by replacing the...
The FDA approved alglucosidase alfa (Lumizyme) for patients ≥8 years of age with late-onset, noninfantile Pompe disease, a rare genetic disorder. Alglucosidase alfa, marketed by Genzyme Corporation, is believed to work by replacing the...
The FDA approved alglucosidase...
06/28/2010
First Report Managed Care
Conference Insider
Outcomes Compared for Patients with Alzheimer’s and Non-Alzheimer’s Dementia
06/28/2010

Charles Boersig

Charles Boersig
A review of records from the National Alzheimer Coordinating Center’s Uniform Data Set (NACC-UDS) found that patients with Alzheimer’s disease (AD) transition more quickly to states of more severe dementia as measured by the Mini-Mental State...
A review of records from the National Alzheimer Coordinating Center’s Uniform Data Set (NACC-UDS) found that patients with Alzheimer’s disease (AD) transition more quickly to states of more severe dementia as measured by the Mini-Mental State...
A review of records from the...
06/28/2010
First Report Managed Care
News Connection
Xifaxan (rifaximin)
06/28/2010
Xifaxan (rifaximin) is a rifamycin antibiotic that is gut selective with negligible systemic absorption and broad-spectrum activity in vitro against pathogens.   
Xifaxan (rifaximin) is a rifamycin antibiotic that is gut selective with negligible systemic absorption and broad-spectrum activity in vitro against pathogens.   
Xifaxan (rifaximin) is a...
06/28/2010
First Report Managed Care
News Connection
Reports Document Growth of HSAs
06/25/2010

Charles Boersig

Charles Boersig
Led by growth among large-group insurers, enrollment in high-deductible health plans (HDHPs) and associated health savings accounts (HSAs) exceeded 10 million this year. Separate research projects recently conducted by America’s Health...
Led by growth among large-group insurers, enrollment in high-deductible health plans (HDHPs) and associated health savings accounts (HSAs) exceeded 10 million this year. Separate research projects recently conducted by America’s Health...
Led by growth among large-group...
06/25/2010
First Report Managed Care
News Connection
Bay State Rate Battle
06/25/2010

Charles Boersig

Charles Boersig
Although 4 of the state’s largest health insurers posted first-quarter losses that they attributed mostly to Governor Deval Patrick’s efforts to slow premium growth rates for individuals and small businesses, the Massachusetts Division of...
Although 4 of the state’s largest health insurers posted first-quarter losses that they attributed mostly to Governor Deval Patrick’s efforts to slow premium growth rates for individuals and small businesses, the Massachusetts Division of...
Although 4 of the state’s...
06/25/2010
First Report Managed Care
Feature
Long-Term Treatment with Asenapine Safe and Effective for Schizophrenia and Schizoaffective Disorder
06/28/2010

Mary Beth Nierengarten

Mary Beth Nierengarten
New Orleans—An extension study that looked at the safety and efficacy of asenapine to treat patients with schizophrenia or schizoaffective disorder found that asenapine remains well tolerated and effective for up to 3 years of treatment. The...
New Orleans—An extension study that looked at the safety and efficacy of asenapine to treat patients with schizophrenia or schizoaffective disorder found that asenapine remains well tolerated and effective for up to 3 years of treatment. The...
New Orleans—An extension study...
06/28/2010
First Report Managed Care
Feature
Pneumococcal Vaccine Does Not Reduce Risk of MI, Stroke in Men
06/28/2010

Kristina Woodworth

Kristina Woodworth
Pneumococcal vaccination does not reduce the risk of acute myocardial infarction or stroke in men ≥45 years of age, according to a study published in the Journal of the American Medical Association.  
Pneumococcal vaccination does not reduce the risk of acute myocardial infarction or stroke in men ≥45 years of age, according to a study published in the Journal of the American Medical Association.  
Pneumococcal vaccination does...
06/28/2010
First Report Managed Care
Feature
End-of-Life Decision Making and the Role of Advance Directives
06/28/2010

Tori Socha

Tori Socha
Discussions prior to passage of recent healthcare reform laws raised awareness of the use of advance directives to direct end-of-life care. Advance directives document a patient’s wishes regarding life-sustaining treatment, choice of a...
Discussions prior to passage of recent healthcare reform laws raised awareness of the use of advance directives to direct end-of-life care. Advance directives document a patient’s wishes regarding life-sustaining treatment, choice of a...
Discussions prior to passage of...
06/28/2010
First Report Managed Care
Feature
Aspirin versus Placebo Does Not Result in Significant Reduction in Vascular Events
06/28/2010

Tim Casey

Tim Casey
In an intention-to-treat, double-blind, randomized controlled trial, researchers found that the administration of aspirin compared with placebo did not result in a significant reduction in vascular events among participants without clinical...
In an intention-to-treat, double-blind, randomized controlled trial, researchers found that the administration of aspirin compared with placebo did not result in a significant reduction in vascular events among participants without clinical...
In an intention-to-treat,...
06/28/2010
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Reviewing a Cost-Effective Treatment Option for RR DLBCL
11/17/2020
Researchers recently examined the cost-effectiveness of a dual treatment among patients with transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma.
Researchers recently examined the cost-effectiveness of a dual treatment among patients with transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma.
Researchers recently examined...
11/17/2020
First Report Managed Care
News
The battle over the health care bill
01/13/2011
01/13/2011
First Report Managed Care
News Connection
Improving Shoulder Surgery Planning Within VA With 3D Printing
05/17/2019
As another continued effort to improve health care services for veterans, the Department of Veteran Affairs (VA) has announced that two doctors from a Baltimore VA Medical Center recently demonstrated how 3D printing at the VA is more useful...
As another continued effort to improve health care services for veterans, the Department of Veteran Affairs (VA) has announced that two doctors from a Baltimore VA Medical Center recently demonstrated how 3D printing at the VA is more useful...
As another continued effort to...
05/17/2019
First Report Managed Care
News
Kathleen Sebelius: Rule coming soon on contraception coverage
03/06/2012
03/06/2012
First Report Managed Care
News
Lundbeck CEO Sees New Drugs Cementing Recovery After Cost Cuts
11/12/2015
The 100-year-old company, which made an operating profit of 3 billion Danish crowns ($431 million) in 2011, plunged into the red after patents on its key drugs ran out in 2012 and 2014.
The 100-year-old company, which made an operating profit of 3 billion Danish crowns ($431 million) in 2011, plunged into the red after patents on its key drugs ran out in 2012 and 2014.
The 100-year-old company, which...
11/12/2015
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

June 2010 Volume 7 Issue 6

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement